{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:32:17Z","timestamp":1786635137368,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Indian Acad Neurol"],"published-print":{"date-parts":[[2008]]},"DOI":"10.4103\/0972-2327.40221","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T06:47:30Z","timestamp":1235026050000},"page":"20","source":"Crossref","is-referenced-by-count":10,"title":["Muscle channelopathies and electrophysiological approach"],"prefix":"10.4103","volume":"11","author":[{"given":"Ajith","family":"Cherian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NeerajN","family":"Baheti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0972-2327.40221-1","first-page":"863","volume-title":"Dihydropyridine receptor mutations cause hypokalemic periodic paralysis","author":"Ptacek","year":"1994","journal-title":"Cell"},{"key":"key-10.4103\/0972-2327.40221-2","first-page":"1415","volume-title":"A calcium channel mutation causing hypokalemic periodic paralysis","author":"Jurkat-Rott","year":"1994","journal-title":"Hum Mol Genet"},{"key":"key-10.4103\/0972-2327.40221-3","first-page":"1091","volume-title":"Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A","author":"Sternberg","year":"2001","journal-title":"Brain"},{"key":"key-10.4103\/0972-2327.40221-4","first-page":"1932","volume-title":"A novel sodium channel mutation in a family with hypokalemic periodic paralysis","author":"Bulman","year":"1999","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.40221-5","first-page":"91","volume-title":"Thyrotoxic, hypokalaemic periodic paralysis in Australasian men","author":"Tran","year":"2003","journal-title":"Intern Med J"},{"key":"key-10.4103\/0972-2327.40221-6","first-page":"1021","volume-title":"Identification of a mutation in the gene causing hyperkalemic periodic paralysis","author":"Ptacek","year":"1991","journal-title":"Cell"},{"key":"key-10.4103\/0972-2327.40221-7","first-page":"1447","volume-title":"Defective slow inactivation of sodium channels contributes to familial periodic paralysis","author":"Hayward","year":"1999","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.40221-8","first-page":"248","volume-title":"Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A)","author":"Hanna","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0972-2327.40221-9","doi-asserted-by":"crossref","unstructured":"Hoskins B, Vroom FQ, Jarrell MA. Hyperkalemic periodic paralysis. Effects of potassium, exercise, glucose and acetazolamide on blood chemistry. Arch Neurol 1975;32:519-23.","DOI":"10.1001\/archneur.1975.00490500039003"},{"key":"key-10.4103\/0972-2327.40221-10","first-page":"305","volume-title":"Andersen\u2032s syndrome: A distinct periodic paralysis","author":"Sansone","year":"1997","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0972-2327.40221-11","doi-asserted-by":"crossref","unstructured":"Plaster NM, Tawil R, Tristani-Firouzi M, Can\u00fan S, Bendahhou S, Tsunoda A, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen\u2032s syndrome. Cell 2001;105:511-9.","DOI":"10.1016\/S0092-8674(01)00342-7"},{"key":"key-10.4103\/0972-2327.40221-12","first-page":"381","volume-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","author":"Tristani-Firouzi","year":"2002","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0972-2327.40221-13","first-page":"466","volume-title":"Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome","author":"Junker","year":"2002","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.40221-14","first-page":"91","volume-title":"Thyrotoxic, hypokalaemic periodic paralysis in Australasian men","author":"Tran","year":"2003","journal-title":"Intern Med J"},{"key":"key-10.4103\/0972-2327.40221-15","first-page":"891","volume-title":"Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita","author":"Ptacek","year":"1992","journal-title":"Neuron"},{"key":"key-10.4103\/0972-2327.40221-16","first-page":"504","volume-title":"Clinical, electrophysiological and molecular genetic studies in a new family with paramyotonia congenita","author":"Davies","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0972-2327.40221-17","first-page":"1095","volume-title":"Myotonia fluctuans: A third type of muscle sodium channel disease","author":"Ricker","year":"1994","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0972-2327.40221-18","first-page":"1500","volume-title":"Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita and hyperkalemic periodic paralysis","author":"Ptacek","year":"1994","journal-title":"Neurology"},{"key":"key-10.4103\/0972-2327.40221-19","first-page":"797","volume-title":"The skeletal muscle chloride channel in dominant and recessive human myotonia","author":"Koch","year":"1992","journal-title":"Science"},{"key":"key-10.4103\/0972-2327.40221-20","first-page":"1753","volume-title":"ClC-1 chloride channel mutations in myotonia congenita: Variable penetrance of mutations shifting the voltage dependence","author":"Kubisch","year":"1998","journal-title":"Hum Mol Genet"},{"key":"key-10.4103\/0972-2327.40221-21","first-page":"2392","volume-title":"Novel CLCN1 mutations with unique clinical and electrophysiological consequences","author":"Wu","year":"2002","journal-title":"Brain"},{"key":"key-10.4103\/0972-2327.40221-22","first-page":"453","volume-title":"Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen\u2032s disease) successfully treated with mexiletine","author":"Ceccarelli","year":"1992","journal-title":"Acta Paediatr"},{"key":"key-10.4103\/0972-2327.40221-23","first-page":"20","volume-title":"Neurological channelopathies","author":"Graves","year":"2005","journal-title":"Postgrad Med J"},{"key":"key-10.4103\/0972-2327.40221-24","first-page":"650","volume-title":"Electromyography guides toward subgroups of mutations in muscle channelopathies","author":"Fournier","year":"2004","journal-title":"Ann Neurol"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:42:17Z","timestamp":1786632137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-2327.40221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"alternative-id":["40221"],"URL":"https:\/\/doi.org\/10.4103\/0972-2327.40221","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}